Results

Total Results: 515 records

Showing results for "renal".

  1. Layout 1 (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_executive-2007.pdf
    January 01, 2007 - Layout 1 This report is an update to a Comparative Effectiveness Review on management strategies for renal … This report does not address the management of fibromuscular dysplasia, renal transplant recipients, … For patients with atherosclerotic renal artery stenosis in the modern management era (i.e., since JNC … on the effects of aggressive medical therapy Comparative Effectiveness of Management Strategies for Renal … Comparative Effectiveness of Management Strategies for Renal Artery Stenosis: 2007 Update.
  2. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0496_12-30-2011.pdf
    January 01, 2011 - Description Nominator: Individual Nomination Summary: The nominator questions the comparative renal … diagnostic procedures requiring the use of contrast media; subgroups of interest include patients with renal … methods, pharmacologic strategies (e.g., Fenoldpam, Mannitol, Theophylline, natriuretic peptides), and renal … biochemical evidence of organ function (serum creatinine or creatinine clearance), mortality, rate of renal … What is the comparative renal safety of different contrast media used in radiographic imaging?
  3. effectivehealthcare-admin.ahrq.gov/products/sodium-potassium/research-protocol
    January 01, 2019 - lithiasis OR nephrolith* OR nephrolithiasis OR renal stone OR renal calculi OR acute kidney injur* … lithiasis OR nephrolith* OR nephrolithiasis OR renal stone OR renal calculi OR "Mortality"[Mesh] OR … lithiasis OR nephrolith* OR nephrolithiasis OR renal stone OR renal calculi AND humans[MESH] OR (( … lithiasis OR nephrolith* OR nephrolithiasis OR renal stone OR renal calculi AND humans[MESH] OR (( … lithiasis OR nephrolith* OR nephrolithiasis OR renal stone OR renal calculi OR "Mortality"[Mesh] OR
  4. effectivehealthcare-admin.ahrq.gov/health-topics/kidney-cancer
    July 18, 2017 - kidneycancer.html Products Clinician Summary Archived July 18, 2017 Management of Renal … Masses and Localized Renal Cell Carcinoma: Current State of the Evidence Systematic Review … Archived February 24, 2016 Management of Renal Masses and Localized Renal Cancer … Research Protocol Archived April 20, 2015 Management of Renal Masses and Localized Renal Cancer
  5. effectivehealthcare-admin.ahrq.gov/sites/default/files/mcda-johnson.pdf
    August 27, 2012 - toxicity, Efficacy, Weight of evidence, Renal toxicity Mean relative importance German … Patients rank toxicity against progression-free survival in second-line treatment of advanced renal … Patients rank toxicity against progression-free survival in second-line treatment of advanced renal … Slide 16 Maximum Acceptable Risk Calculation Renal Cell Carcinoma Image: Bar chart showing 3 month … Patients rank toxicity against progression-free survival in second-line treatment of advanced renal
  6. effectivehealthcare-admin.ahrq.gov/products/kidney-stone-prevention/research-protocol
    December 01, 2019 - Large struvite stones remain in the renal pelvis and may not cause pain. … Exclusion: 1) Patients with ongoing acute renal colic, 2) patients undergoing treatment to assist in … colic, acute renal failure) Quality of life (general, urologic) End-stage renal disease Intermediate … calcul* or kidney stone*).mp. 3 renal colic.mp. or exp Renal Colic/ 4 hypercalciuria.mp. or exp … Decreased renal function among adults with a history of nephrolithiasis: a study of NHANES III.
  7. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_executive.pdf
    January 01, 2012 - However, these renal endpoints are not clinical outcomes. … United States Renal Data System. … Renal Disease in the United States. … Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. … Renal Association.
  8. Slide 1 (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/johnson_-ahrq-mcda-presentation.pdf
    August 27, 2012 - Most important Least important German patients Renal toxicity Weight of … Patients rank toxicity against progression-free survival in second-line treatment of advanced renal … RTI International Research Triangle Institute Maximum Acceptable Risk Calculation Renal Cell Carcinoma … Patients rank toxicity against progression-free survival in second-line treatment of advanced renal … Patients rank toxicity against progression-free survival in second-line treatment of advanced renal
  9. effectivehealthcare-admin.ahrq.gov/sites/default/files/data-points_1_diabetic-foot-ulcers_data_02-2011.pdf
    January 01, 2011 - Diabetes Rate in Enrolled Population Total All 2006 32.8 8.7 26.4% Age Disabled/end stage renal … Indian/Alaska Native 2006 0.1 0.1 36.0% Total All 2007 32.3 8.8 27.3% Age Disabled/end stage renal … Indian/Alaska Native 2007 0.2 0.1 37.3% Total All 2008 31.9 8.9 27.9% Age Disabled/end stage renal … Indian/Alaska Native 2006 9.7% 28.4% 6.4% Total All 2007 8.1% 18.9% 5.0% Age Disabled/end stage renal … of Major and Minor LEA in the Same Year Total All 2006 1.4% 0.5% 0.3% Age Disabled/end stage renal
  10. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/sodium-potassium_research-protocol.pdf
    April 18, 2017 - lithiasis OR nephrolith* OR nephrolithiasis OR renal stone OR renal calculi OR acute kidney injur* … lithiasis OR nephrolith* OR nephrolithiasis OR renal stone OR renal calculi OR "Mortality"[Mesh] OR … lithiasis OR nephrolith* OR nephrolithiasis OR renal stone OR renal calculi AND humans[MESH] OR ( … lithiasis OR nephrolith* OR nephrolithiasis OR renal stone OR renal calculi AND "Prospective Studies … lithiasis OR nephrolith* OR nephrolithiasis OR renal stone OR renal calculi OR "Mortality"[Mesh] OR
  11. effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/1-does-mass-spectrometric-analysis-and-therapeutic-monitoring-of-tacrolimus-as-compared-with-immunoassay-analysis-and-therapeutic-monitoring-produce-a-better-organ-survival-rate-b-fewer-rejections-c-less-nephrotoxicity-andor
    November 01, 2017 - better organ survival rate, b) fewer rejections, c) less nephrotoxicity and/or d) cost savings in renal … better organ survival rate, b) fewer rejections, c) less nephrotoxicity, and/or d) cost savings in renal … organ survival rate, b) fewer rejection episodes, c) less nephrotoxicity,and/or d) cost savings in renal … adult renal patients Are there subgroups of patients that your question might apply to? … In addition, 31% of deaths in renal transplant patients were deaths with a functioning graft from co
  12. effectivehealthcare-admin.ahrq.gov/sites/default/files/data-points_2_diabetic-foot-ulcers_data_02-2011.pdf
    January 01, 2011 - Beneficiaries With Diabetes and Without PAD Total All 2006 6.0% 13.5% 4.0% Age Disabled/end stage renal … Indian/Alaska Native 2006 6.9% 17.9% 5.0% Total All 2007 6.0% 13.2% 4.0% Age Disabled/end stage renal … /Alaska Native 2006 1.0% 5.6% 0.135% Total All 2007 0.5% 1.9% 0.055% Age Disabled/end stage renal … /Alaska Native 2007 0.8% 4.7% 0.131% Total All 2008 0.4% 1.8% 0.058% Age Disabled/end stage renal … Diabetic Population Q1 Q2 Q3 Q4 Total All 2006 0.18% 0.14% 0.12% 0.12% Age Disabled/end stage renal
  13. effectivehealthcare-admin.ahrq.gov/products/osteoarthritis-pain/research-protocol
    December 01, 2019 - -200 mg/day; RA: delayed release, 100-200 mg/day in 3 to 4 doses; extended release, 75-225 mg/day Renal … primary dysmenorrhea; rheumatoid arthritis OA and RA: 1200-3200 mg/day in 3 to 4 divided doses Renal … to 3x/day or a maximum dose of 100 mg 2x/day; sustained release product, 75 mg 1 to 2x/day Severe renal … Peds: lowest effective dose for shortest possible duration; >65 years of age or weight <50 kg or renal … ; osteoarthritis; rheumatoid arthritis OA and RA: 7.5 mg 1x/day; maximum, 15 mg 1x/day Elderly, renal
  14. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/nephropathy-contrast-induced_clinician.pdf
    August 01, 2016 - Renal Disease Nephropathy Background Numerous strategies have been used to try to prevent CIN, including … Leading theories state that CIN results from hypoxic injury of the renal tubules induced by renal vasoconstriction … ��� Development of CIN (with IA administration) 18d 4194 ⬌ – 0.80 (0.64 to 1.01) ��� Need for renal … e Renal replacement therapy consisted of hemodialysis or hemofiltration. … g Renal replacement therapy consisted of hemodialysis or hemofiltration.
  15. effectivehealthcare-admin.ahrq.gov/health-topics/high-blood-pressure
    March 04, 2022 - Disease Outcomes and Related Risk Factors Systematic Review Archived August 16, 2016 Renal … Updated Comparative Effectiveness Review Research Protocol Archived January 20, 2015 Renal … Comparative Effectiveness of Antihypertensive Therapies on Cardiovascular Disease Outcomes In End-Stage Renal … Review Archived November 19, 2007 Comparative Effectiveness of Management Strategies for Renal … Systematic Review Archived October 24, 2006 Comparative Effectiveness of Management Strategies for Renal
  16. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/nephropathy-contrast-induced_research-protocol.pdf
    October 01, 2013 - Objectives for the Systematic Review Contrast induced nephropathy (CIN) is defined as impairment of renal … If renal function returns to normal, it usually does so within 7 to 10 days after contrast medium administration … to CKD at 3 and 6 months ● Chronic change in kidney function b) Renal disease-specific outcomes … disease; KQ=Key question; RRT=renal replacement therapy Source: www.effectivehealthcare.ahrq.gov … In 1% of all patients undergoing contrast enhanced CT the decline in renal function persisted.
  17. effectivehealthcare-admin.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-year-in-review-2024.pdf
    January 01, 2024 - particularly important for people with chronic kidney disease (CKD), particularly those with end-stage renal … Including payment for dental coverage for people with end- stage renal disease receiving dialysis removes … CMS physician fee schedule to provide oral health coverage under Medicare for people with end-stage renal … This change may improve outcomes for people with end-stage renal disease receiving dialysis as well
  18. effectivehealthcare-admin.ahrq.gov/products/acute-pain-treatment/technical-brief
    March 01, 2020 - for several acute pain conditions including postoperative pain, dental pain, neck pain, back pain, renal … overview of systematic reviews include postoperative postdischarge pain, acute back pain, acute neck pain, renal … warrant a new systematic review: pain associated with dental procedures and oral surgery, low back pain, renal … pain conditions (postdischarge postoperative pain, musculoskeletal pain, acute migraine, dental pain, renal
  19. effectivehealthcare-admin.ahrq.gov/health-topics/surgery?page=0
    March 10, 2025 - Cell Carcinoma of the Skin Clinician Summary Archived July 18, 2017 Management of Renal … Masses and Localized Renal Cell Carcinoma: Current State of the Evidence Systematic Review … of Uterine Fibroids Systematic Review Archived February 24, 2016 Management of Renal … Masses and Localized Renal Cancer Pagination 1 2 3 4 5
  20. effectivehealthcare-admin.ahrq.gov/health-topics/surgery
    March 10, 2025 - Cell Carcinoma of the Skin Clinician Summary Archived July 18, 2017 Management of Renal … Masses and Localized Renal Cell Carcinoma: Current State of the Evidence Systematic Review … of Uterine Fibroids Systematic Review Archived February 24, 2016 Management of Renal … Masses and Localized Renal Cancer Pagination 1 2 3 4 5

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: